Matthew P. Goetz, M.D.
Consultant, Division of Medical Oncology, Mayo Clinic
Matthew P. Goetz, M.D., is a consultant in the Division of Medical Oncology at Mayo Clinic in Rochester, Minn. He holds the academic rank of associate professor of oncology and pharmacology in the College of Medicine, Mayo Clinic.
Dr. Goetz's research focus is in the area of estrogen receptor positive breast cancer and the pharmacogenomics of anti-cancer therapy. His work in the area of tamoxifen drug metabolism and pharmacogenetics led to a Food and Drug Administration recommendation to change the label of tamoxifen, and it has more recently focused on developing a novel formulation of the active metabolite of tamoxifen.
Dr. Goetz received his M.D. from the University of North Dakota School of Medicine and Health Sciences. After completing both an internship and residency in internal medicine at the University of Michigan, he completed a postdoctoral fellowship in hematology and oncology at Mayo Clinic.
2012 conference presentation